COVID-19 vaccines require a cold chain plan that follows the product label, local health authority rules, and the shipper’s validated SOP. The packaging should protect the approved temperature range, vial condition, Lesbarkeit des Etiketts, and receiving release decision.
COVID-19 vaccine programs should not use a generic vaccine box without checking the current product label and local health authority instructions.
Some routes may need refrigerated handling, while others may involve frozen or Trockeneis Logistik. These are separate packout validations.
The receiving team should know how to read the logger, inspect shipper condition, and quarantine product if the approved range is not confirmed.
Cold chain planning data
| Temperaturfenster | Produktspezifisch: gekühlt, gefroren, or ultra-low temperature requirements depend on manufacturer labeling. |
|---|---|
| Humidity or moisture | Keep cartons dry and protect vial trays, Etiketten, and secondary packaging from condensation. |
| Vorkühlung | Condition the shipper, Kühlmittel, Datenlogger, and staging area to the product's approved range before loading. |
| Packaging pressure | Protect vial trays and cartons from hard coolant, Trockeneisblöcke, and vibration during parcel or validated courier transport. |
| Kühlmittelplatzierung | Use gel packs, Phasenwechselmaterial, Tiefkühlpackungen, or dry ice only when the product label, SOP, and carrier rules allow it. |
| Transitdauer | Validate each route by product, Versendergröße, Kühlmittelmasse, Nachschubplan, und Lieferfenster. |
| Common losses | Temperaturexkursion, dry ice depletion, Kondensation, Beschädigung des Etiketts, vial tray movement, and quarantine at receiving. |
| Suitable Tempk packout | Tempk validated insulated shipper, product-specific coolant map, continuous temperature logger, and receiving excursion workflow. |
Recommended packout approach
Start with product that is already within the approved storage range. Condition the shipper and coolant before loading, use a barrier between coolant and product cartons, and place the temperature logger in a representative product zone rather than directly against coolant.
Für gekühlte Impfstoffe, the main packaging risk is often freeze exposure from poorly conditioned Gelpackungen. For frozen or ultra-low temperature programs, Trockeneismasse, Belüftung, Trägerregeln, Zeitpunkt der Wiederauffüllung, and logger placement require a separate validation plan.
Quality checks before release
Before commercial use, test the actual carton size, Produktladung, Kühlmittelmasse, Streckenlänge, ambient season, and receiving window. At arrival, check temperature data, carton dryness, Etikettenzustand, vial movement, Kühlmittelzustand, and any product-specific excursion instructions.
Tempk can support 2-8 C, gefroren, or dry ice-compatible packout planning, but final release decisions should always follow the vaccine manufacturer’s instructions and the customer’s quality system.
Reference basis
Temperature guidance is based on CDC vaccine storage and handling resources and WHO Kühlkette für Impfstoffe üben. Always confirm the current package insert before shipment.
